The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "opioids"

Search results for: opioids

Opioids Commonly Prescribed for Gout Attacks

July 9, 2019 • By Reuters Staff

NEW YORK (Reuters Health)—Nearly three in 10 patients seeking care at the emergency department (ED) for acute gout will be discharged with a prescription for opioids, new research shows. “Our study suggests a high use of prescription opioid in patients discharged from the ED with a diagnosis of gout, a condition that can be managed… [Read More]

Filed Under: Conditions, Crystal Arthritis Tagged With: Arthritis Care & Research, Emergency Department, Gout, opioid, Pain, Pain Management

Annual Meeting Speakers Review Studies Ranging from Opioids to Fibroblasts

December 18, 2018 • By Thomas R. Collins

CHICAGO—Findings on opioid efficacy, serum urate in osteoarthritis and arthrocentesis headlined the top research of the year discussed in the first half of a session at the 2018 ACR/ARHP Annual Meeting. The second half covered basic science findings, including summaries of new insights into the gender bias in autoimmune diseases, platelet microparticles in scleroderma and… [Read More]

Filed Under: Meeting Reports, Research Reviews Tagged With: 2018 ACR/ARHP Annual Meeting, arthrocentesis, fibroblasts, Gender, opioid efficacy, Osteoarthritis, Rheumatoid Arthritis (RA), Scleroderma

FDA Expands Safety Measures for Immediate Release Opioids

October 2, 2018 • By Michele B. Kaufman, PharmD, BCGP

The FDA has expanded the new Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) to include immediate release opioids. The program, which also includes extended release and long acting opioids, will provide education to prescribers and healthcare professionals…... [Read More]

Filed Under: Analgesics, Drug Updates Tagged With: FDA, immediate release opioids, Opioids, REMS, Safety, U.S. Food and Drug Administration (FDA)

Nonopioid Medication May Be as Effective as Opioids for Chronic Pain

April 16, 2018 • By Lara C. Pullen, PhD

A recent study compared the efficacy of opioids with nonopioid pain treatments in patients with chronic back pain and hip or knee osteoarthritis. After 12 months, researchers found that treatment with opioids was not superior to treatment with nonopioid medication, with only minor differences in patients’ functional responses to the medications…... [Read More]

Filed Under: Analgesics, Drug Updates Tagged With: Chronic pain, opioid, opioid alternatives, Pain, Pain Management

Opioids No Better Than NSAIDs for Chronic Back or Arthritis Pain

March 7, 2018 • By Lisa Rapaport

(Reuters Health)—Acetaminophen, ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) are better than opioids at easing the intensity of chronic pain in the back, knees or hips, a U.S. experiment suggests. And opioids are no better than these other drugs at reducing how much pain interferes with daily activities, such as walking, working, sleeping or enjoying… [Read More]

Filed Under: Analgesics, Drug Updates Tagged With: Chronic pain, hip, hip pain, Knee Osteoarthritis (OA), Nonsteroidal anti-inflammatory drugs (NSAIDs), NSAIDs, Opioids, osteoarthritis (OA), Pain, Pain Management

Wal-Mart Launches Program to Safely Dispose of Unused Opioids

January 17, 2018 • By Reuters Staff

NEW YORK (Reuters)—Wal-Mart Stores Inc on Wednesday said it will provide customers filling prescriptions for opioids with a packet of powder that will help them dispose of leftover medication in order to help curb misuse and abuse. The company said patients filling any new class II opioid prescriptions at its pharmacies will receive a free… [Read More]

Filed Under: Drug Updates Tagged With: leftover medication disposal program, national opioid addiction epidemic, opioid crisis, Wal-Mart Stores Inc

Trump Administration Proposes Medicare Rules Aimed at Opioids, Drug Costs

November 17, 2017 • By Deena Beasley

(Reuters)—The Trump administration on Thursday proposed changes to Medicare drug plans including limits on opioid prescriptions and rules aimed at reducing drug costs for seniors, such as requiring health insurers to pass on discounts to consumers. To help combat overprescription and abuse of addictive painkillers, the U.S. Centers for Medicare and Medicaid Services (CMS) said… [Read More]

Filed Under: Drug Updates Tagged With: drug costs, Medicare, Opioids, prescription drug costs, Trump administration

Trump Declares Opioids a U.S. Public Health Emergency

October 27, 2017 • By Yasmeen Abutaleb and Jeff Mason

WASHINGTON (Reuters)—U.S. President Donald Trump declared the opioid crisis a public health emergency on Thursday, stopping short of a national emergency declaration he promised months ago that would have freed up more federal money. Responding to a growing problem wreaking havoc in rural areas, Trump’s declaration will redirect federal resources and loosen regulations to combat… [Read More]

Filed Under: Drug Updates, Pharma Co. News Tagged With: Fentanyl, heroin, national opioid addiction epidemic, opioid crisis, prescription painkillers, rising death rate, U.S. public health emergency

FDA Sets Stricter Requirements for Immediate-Release Opioids to Prevent Misuse & Abuse

October 27, 2017 • By Michele B. Kaufman, PharmD, BCGP

The FDA is expanding its Risk Evaluation and Mitigation Strategy (REMS) to include manufacturers of immediate-release opioids. The makers of these drugs will soon be required to provide training and education to healthcare professionals on the proper prescription and use of the drugs for pain management…... [Read More]

Filed Under: Analgesics, Drug Updates Tagged With: FDA, opioid, Opioid abuse, REMS, U.S. Food and Drug Administration (FDA)

Makers of Fast-Acting Opioids Will Have to Pay for Training—FDA

September 29, 2017 • By Michael Erman

NEW YORK (Reuters)—Makers of fast-acting opioids will have to fund voluntary training for healthcare professionals who prescribe the drugs, including education on safe prescribing practices and non-opioid alternatives, the course  said on Thursday. The FDA sent letters to 74 manufacturers of immediate-release opioids, notifying them that they will have to fund the development of courses… [Read More]

Filed Under: Drug Updates, Education & Training Tagged With: course funding, fast-acting opioids, opioid drug companies, U.S. Food and Drug Administration (FDA), voluntary training

  • 1
  • 2
  • 3
  • …
  • 18
  • Next Page »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR/ARP Meeting Abstracts

Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.

Visit the ACR/ARP Meeting Abstracts site »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.